{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:00:47Z","timestamp":1786788047880,"version":"build-2736575974"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T00:00:00Z","timestamp":1732060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["SPG\/2021\/004561"],"award-info":[{"award-number":["SPG\/2021\/004561"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","award":["CRG\/2022\/001009"],"award-info":[{"award-number":["CRG\/2022\/001009"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s12033-024-01311-6","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T02:20:02Z","timestamp":1732069202000},"page":"4212-4232","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrative Investigation of Flavonoids Targeting YBX1 Protein\u2013Protein Interaction Network in Breast Cancer: From Computational Analysis to Experimental Validation"],"prefix":"10.1007","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9399-3038","authenticated-orcid":false,"given":"Presanna Kumar","family":"Sreelekshmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suresh Kumar","family":"Pooja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9187-7753","authenticated-orcid":false,"given":"Niranjan","family":"Vidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0950-7513","authenticated-orcid":false,"given":"Skariyachan","family":"Sinosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5831-9255","authenticated-orcid":false,"given":"Venkatesh","family":"Thejaswini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,20]]},"reference":[{"key":"1311_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2021.110073","volume":"85","author":"A Alkrekshi","year":"2021","unstructured":"Alkrekshi, A., Wang, W., Rana, P. S., Markovic, V., & Sossey-Alaoui, K. (2021). A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance. Cellular Signalling, 85, 110073. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110073","journal-title":"Cellular Signalling"},{"issue":"7","key":"1311_CR2","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1111\/j.1349-7006.2011.01948.x","volume":"102","author":"C Garand","year":"2011","unstructured":"Garand, C., Guay, D., Sereduk, C., Chow, D., Tsofack, S. P., Langlois, M., Perreault, \u00c8., Yin, H. H., & Lebel,\nM. (2011). An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF-7 and MDA-MB-231 breast cancer cells. Cancer Science, 102(7), 1410\u20131417. https:\/\/doi.org\/10.1111\/j.1349-7006.2011.01948.x","journal-title":"Cancer Science"},{"issue":"3","key":"1311_CR3","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1158\/1535-7163.mct-19-0690","volume":"19","author":"T Shibata","year":"2019","unstructured":"Shibata, T., Watari, K., Kawahara, A., Sudo, T., Hattori, S., Murakami, Y.,  Izumi, H., Itou, J., Toi, M., Akiba, J.,\nAkagi, Y., Tanaka, M., Kuwano, M., & Ono, M. (2019). Targeting phosphorylation of Y-Box-Binding protein YBX1 by TAS0612 and everolimus in overcoming antiestrogen resistance. Molecular Cancer Therapeutics, 19(3), 882\u2013894. https:\/\/doi.org\/10.1158\/1535-7163.mct-19-0690","journal-title":"Molecular Cancer Therapeutics"},{"issue":"11","key":"1311_CR4","doi-asserted-by":"publisher","first-page":"5997","DOI":"10.1074\/jbc.273.11.5997","volume":"273","author":"T Ohga","year":"1998","unstructured":"Ohga, T., Uchiumi, T., Makino, Y., Koike, K., Wada, M., Kuwano, M., & Kohno, K. (1998). Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. Journal of Biological Chemistry, 273(11), 5997\u20136000. https:\/\/doi.org\/10.1074\/jbc.273.11.5997","journal-title":"Journal of Biological Chemistry"},{"issue":"2","key":"1311_CR5","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1158\/0008-5472.can-17-1153","volume":"78","author":"TM Campbell","year":"2018","unstructured":"Campbell, T. M., Castro, M. A. A., De Oliveira, K. G., Ponder, B. A., & Meyer, K. B. (2018). ER\u0391 binding by transcription factors NFIB and YBX1 enables FGFR2 signaling to modulate estrogen responsiveness in breast cancer. Cancer Research, 78(2), 410\u2013421. https:\/\/doi.org\/10.1158\/0008-5472.can-17-1153","journal-title":"Cancer Research"},{"key":"1311_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2555-4","author":"Y Cui","year":"2020","unstructured":"Cui, Y., Li, F., Xie, Q., Zhao, S., Guo, T., Guo, P., Hu, S., Hao, J., Tian, C., Yu, W., Li, Z., Fang, L., Zhao, L.,\nChen, M., Wu, T., & Gu, C. (2020). YBX1 mediates autophagy by targeting p110\u03b2 and decreasing the sensitivity to cisplatin in NSCLC. Cell Death and Disease. https:\/\/doi.org\/10.1038\/s41419-020-2555-4","journal-title":"Cancer Research"},{"issue":"19","key":"1311_CR7","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1093\/jnci\/djt210","volume":"105","author":"Y Kang","year":"2013","unstructured":"Kang, Y., Hu, W., Ivan, C., Dalton, H. J., Miyake, T., Pecot, C. V., Zand, B., Liu, T., Huang, J., Jennings, N. B.,\nRupaimoole, R., Taylor, M., Pradeep, S., Wu, S. Y., Lu, C., Wen, Y., Huang, J., Liu, J., & Sood, A. K. (2013). Role of focal adhesion kinase in regulating YB-1-mediated paclitaxel resistance in ovarian cancer. Journal of the National Cancer Institute, 105(19), 1485\u20131495. https:\/\/doi.org\/10.1093\/jnci\/djt210","journal-title":"Journal of the National Cancer Institute"},{"issue":"10","key":"1311_CR8","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1007\/s00345-014-1469-0","volume":"33","author":"M Saupe","year":"2014","unstructured":"Saupe, M., Rauschenberger, L., Preu\u00df, M., Oswald, S., Fussek, S., Zimmermann, U., Walther, R., Knabbe, C.,\nBurchardt, M., & Stope, M. B. (2014). Differential expression of the multidrug resistance 1 (MDR1) protein in prostate cancer cells is independent from anticancer drug treatment and Y box binding protein 1 (YB-1) activity. World Journal of Urology, 33(10), 1481\u20131486. https:\/\/doi.org\/10.1007\/s00345-014-1469-0","journal-title":"World Journal of Urology"},{"issue":"2","key":"1311_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/leu.2012.185","volume":"27","author":"KS Bommert","year":"2012","unstructured":"Bommert, K. S., Effenberger, M., Leich, E., K\u00fcspert, M., Murphy, D., Langer, C., Moll, R., Janz, S., Mottok, A.,\nWeissbach, S., Rosenwald, A., Bargou, R., & Bommert, K. (2012). The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival. Leukemia, 27(2), 441\u2013450. https:\/\/doi.org\/10.1038\/leu.2012.185","journal-title":"Leukemia"},{"issue":"2","key":"1311_CR10","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1158\/0008-5472.can-16-1593","volume":"77","author":"T Shibata","year":"2016","unstructured":"Shibata, T., Watari, K., Izumi, H., Kawahara, A., Hattori, S., Fukumitsu, C., Murakami, Y., Takahashi, R., Toh,\nU., Ito, K., Ohdo, S., Tanaka, M., Kage, M., Kuwano, M., & Ono, M. (2016). Breast cancer resistance to antiestrogens is enhanced by increased ER degradation and ERBB2 expression. Cancer Research,  77(2), 545\u2013556. https:\/\/doi.org\/10.1158\/0008-5472.can-16-1593","journal-title":"Cancer Research"},{"issue":"5","key":"1311_CR11","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1111\/cas.14006","volume":"110","author":"M Kuwano","year":"2019","unstructured":"Kuwano, M., Shibata, T., Watari, K., & Ono, M. (2019). Oncogenic Y-box binding protein-1 as an effective therapeutic target in drug-resistant cancer. Cancer Science, 110(5), 1536\u20131543. https:\/\/doi.org\/10.1111\/cas.14006","journal-title":"Cancer Science"},{"issue":"5","key":"1311_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1634\/theoncologist.8-5-411","volume":"8","author":"GD Leonard","year":"2003","unstructured":"Leonard, G. D., Fojo, T., & Bates, S. E. (2003). The role of ABC transporters in clinical practice. The Oncologist, 8(5), 411\u2013424. https:\/\/doi.org\/10.1634\/theoncologist.8-5-411","journal-title":"The Oncologist"},{"issue":"6","key":"1311_CR13","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.3892\/ijo.2016.3451","volume":"48","author":"H Izumi","year":"2016","unstructured":"Izumi, H., Nagao, S., Mochizuki, S., Fujiwara, N., Sakurai, K., & Morimoto, Y. (2016). Optimal sequence of antisense DNA to silence YB-1 in lung cancer by use of a novel polysaccharide drug delivery system. International Journal of Oncology, 48(6), 2472\u20132478. https:\/\/doi.org\/10.3892\/ijo.2016.3451","journal-title":"International Journal of Oncology"},{"issue":"9","key":"1311_CR14","doi-asserted-by":"publisher","first-page":"e12661","DOI":"10.1371\/journal.pone.0012661","volume":"5","author":"JH Law","year":"2010","unstructured":"Law, J. H., Li, Y., To, K., Wang, M., Astanehe, A., Lambie, K., Dhillon, J., Jones, S. J. M., Gleave, M. E.,\nEaves, C. J., & Dunn, S. E. (2010). Molecular decoy to the Y-box binding protein-1 suppresses the growth of breast and prostate cancer cells whilst sparing normal cell viability. PLoS ONE, 5(9), e12661. https:\/\/doi.org\/10.1371\/journal.pone.0012661.","journal-title":"PLoS ONE"},{"key":"1311_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00387-6","author":"W Gao","year":"2022","unstructured":"Gao, W., Chen, L., Lin, L., Yang, M., Li, T., Wei, H., Sha, C., Xing, J., Zhang, M., Zhao, S., Chen, Q., Xu, W.,\nLi, Y., &  Zhu, X. (2022). SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1. Oncogenesis. https:\/\/doi.org\/10.1038\/s41389-022-00387-6","journal-title":"Oncogenesis"},{"key":"1311_CR16","doi-asserted-by":"publisher","DOI":"10.1017\/jns.2016.41","author":"AN Panche","year":"2016","unstructured":"Panche, A. N., Diwan, A. D., & Chandra, S. (2016). Flavonoids: An overview. Journal of Nutritional Science. https:\/\/doi.org\/10.1017\/jns.2016.41","journal-title":"Journal of Nutritional Science"},{"issue":"2","key":"1311_CR17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10549-008-0118-y","volume":"115","author":"T Rabi","year":"2008","unstructured":"Rabi, T., & Bishayee, A. (2008). Terpenoids and breast cancer chemoprevention. Breast Cancer Research and Treatment, 115(2), 223\u2013239. https:\/\/doi.org\/10.1007\/s10549-008-0118-y","journal-title":"Breast Cancer Research and Treatment"},{"issue":"12","key":"1311_CR18","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3390\/biom11121841","volume":"11","author":"K Zhai","year":"2021","unstructured":"Zhai, K., Mazur\u00e1kov\u00e1, A., Koklesov\u00e1, L., Kubatka, P., & B\u00fcsselberg, D. (2021). Flavonoids synergistically enhance the Anti-Glioblastoma effects of chemotherapeutic drugs. Biomolecules, 11(12), 1841. https:\/\/doi.org\/10.3390\/biom11121841","journal-title":"Biomolecules"},{"key":"1311_CR19","doi-asserted-by":"publisher","DOI":"10.3892\/wasj.2020.47","author":"R Raina","year":"2020","unstructured":"Raina, R., Hussain, A., & Sharma, R. (2020). Molecular insight into apoptosis mediated by flavones in cancer (Review). World Academy of Sciences Journal. https:\/\/doi.org\/10.3892\/wasj.2020.47","journal-title":"World Academy of Sciences Journal"},{"issue":"1","key":"1311_CR20","doi-asserted-by":"publisher","first-page":"11255","DOI":"10.1038\/s41598-018-29308-7","volume":"8","author":"H-W Zhang","year":"2018","unstructured":"Zhang, H.-W., Hu, J., Fu, R., Liu, X., Zhang, Y., Li, J., Liu, L., Li, Y., Deng, Q., Luo, Q., Ouyang, Q., & Gao, N. (2018). Flavonoids inhibit cell proliferation and induce apoptosis and autophagy through downregulation of PI3K\u03b3 mediated PI3K\/AKT\/MTOR\/p70S6K\/ULK signalling pathway in human breast cancer cells. Scientific Reports, 8(1), 11255. https:\/\/doi.org\/10.1038\/s41598-018-29308-7","journal-title":"Scientific Reports"},{"issue":"12","key":"1311_CR21","doi-asserted-by":"publisher","first-page":"21519","DOI":"10.1002\/jcp.28777","volume":"234","author":"K Afshari","year":"2019","unstructured":"Afshari, K., Haddadi, N., Haj-Mirzaian, A., Farzaei, M. H., Rohani, M., Akramian, F., & Abdolghaffari, A. H. (2019). Natural flavonoids for the prevention of colon cancer: A comprehensive review of preclinical and clinical studies. Journal of Cellular Physiology, 234(12), 21519\u201321546. https:\/\/doi.org\/10.1002\/jcp.28777","journal-title":"Journal of Cellular Physiology"},{"issue":"6","key":"1311_CR22","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/mnfr.201600025","volume":"60","author":"RK Lall","year":"2016","unstructured":"Lall, R. K., Adhami, V. M., & Mukhtar, H. (2016). Dietary flavonoid Fisetin for cancer prevention and treatment. Molecular Nutrition and Food Research, 60(6), 1396\u20131405. https:\/\/doi.org\/10.1002\/mnfr.201600025","journal-title":"Molecular Nutrition and Food Research"},{"issue":"4","key":"1311_CR23","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1039\/c6fo00551a","volume":"8","author":"T Lin","year":"2017","unstructured":"Lin, T., Hsu, W., Tsai, P., Huang, Y., Lin, C., Chen, K., .Tsai, I., Kandaswami, C. C., Huang, C., Chang, G.,\nLee, M., & Cheng, C. (2017). Dietary flavonoids, luteolin and Quercetin, inhibit invasion of cervical cancer by reduction of UBE2S through epithelial\u2013mesenchymal transition signaling. Food and Function,  8(4), 1558\u20131568. https:\/\/doi.org\/10.1039\/c6fo00551a.","journal-title":"Food and Function"},{"issue":"4","key":"1311_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03803","volume":"6","author":"A Sharma","year":"2020","unstructured":"Sharma, A., Parikh, M., Shah, H., & Gandhi, T. (2020). Modulation of Nrf2 by Quercetin in doxorubicin-treated rats. Heliyon, 6(4), e03803. https:\/\/doi.org\/10.1016\/j.heliyon.2020.e03803","journal-title":"Heliyon"},{"issue":"9","key":"1311_CR25","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.18632\/oncotarget.1790","volume":"5","author":"MI Khan","year":"2014","unstructured":"Khan, M. I., Adhami, V. M., Lall, R. K., Sechi, M., Joshi, D. C., Haidar, O. M., Syed, D. N., Siddiqui, I. A., Chiu, S., & Mukhtar, H. (2014). YB-1 expression promotes epithelial-to-mesenchymal transition in prostate cancer that is inhibited by a small molecule Fisetin. Oncotarget, 5(9), 2462\u20132474. https:\/\/doi.org\/10.18632\/oncotarget.1790","journal-title":"Oncotarget"},{"key":"1311_CR26","doi-asserted-by":"publisher","DOI":"10.7554\/elife.80387","author":"KE Hage","year":"2023","unstructured":"Hage, K. E., Babault, N., Maciejak, O., Desforges, B., Craveur, P., Steiner, E., Rengifo-Gonzalez, J. C., Henrie, H., Clement, M., Joshi, V., Bouhss, A., Wang, L., Bauvais, C., & Pastr\u00e9, D. (2023). Targeting RNA:protein interactions with an integrative approach leads to the identification of potent YBX1 inhibitors. eLife. https:\/\/doi.org\/10.7554\/elife.80387","journal-title":"eLife"},{"key":"1311_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33879-w","author":"M Sechi","year":"2018","unstructured":"Sechi, M., Lall, R. K., Afolabi, S. O., Singh, A., Joshi, D. C., Chiu, S., Mukhtar, H., & Syed, D. N. (2018). Fisetin targets YB-1\/RSK axis independent of its effect on ERK signaling: Insights from in vitro and in vivo melanoma models. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-018-33879-w","journal-title":"Scientific Reports"},{"issue":"7","key":"1311_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1083\/jcb.201411047","volume":"208","author":"SP Somasekharan","year":"2015","unstructured":"Somasekharan, S. P., El-Naggar, A., Leprivier, G., Cheng, H., Hajee, S., Grunewald, T. G., Zhang, F., Ng, T., Delattre, O., Evdokimova, V., Wang, Y., Gleave, M., & Sorensen, P. H. (2015). YB-1 regulates stress granule formation and tumor progression by translationally activating G3BP1. The Journal of Cell Biology, 208(7), 913\u2013929. https:\/\/doi.org\/10.1083\/jcb.201411047","journal-title":"The Journal of Cell Biology"},{"issue":"D1","key":"1311_CR29","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2018","unstructured":"Szklarczyk, D., Gable, A. L., Lyon, D., Junge, A., Wyder, S., Huerta-Cepas, J., Simonovic, M., Doncheva, N. T., Morris, J. H., Bork, P., Jensen, L. J., & Von Mering, C. (2018). STRING v11: Protein\u2013protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Research, 47(D1), D607\u2013D613. https:\/\/doi.org\/10.1093\/nar\/gky1131","journal-title":"Nucleic Acids Research"},{"key":"1311_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1758-2946-3-33","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. (2011). Open Babel: An open chemical toolbox. Journal of Cheminformatics. https:\/\/doi.org\/10.1186\/1758-2946-3-33","journal-title":"Journal of Cheminformatics"},{"issue":"16","key":"1311_CR31","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris, G. M., Huey, R., Lindstrom, W. M., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785\u20132791. https:\/\/doi.org\/10.1002\/jcc.21256","journal-title":"Journal of Computational Chemistry"},{"issue":"W1","key":"1311_CR32","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., De Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Research"},{"key":"1311_CR33","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The Protein Data Bank. Nucleic Acids Research, 28, 235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Research"},{"key":"1311_CR34","unstructured":"Dassault Syst\u00e8mes. (2023, December 8). Discovery Studio. Dassault Syst\u00e8mes. https:\/\/www.3ds.com\/products\/biovia\/discovery-studio"},{"issue":"2","key":"1311_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2009","unstructured":"Trott, O., & Olson, A. J. (2009). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455\u2013461. https:\/\/doi.org\/10.1002\/jcc.21334","journal-title":"Journal of Computational Chemistry"},{"issue":"W1","key":"1311_CR36","doi-asserted-by":"publisher","first-page":"W5","DOI":"10.1093\/nar\/gkab255","volume":"49","author":"G Xiong","year":"2021","unstructured":"Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., Chen, X., Hou, T., & Cao, D. (2021). ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties. Nucleic Acids Research, 49(W1), W5\u2013W14. https:\/\/doi.org\/10.1093\/nar\/gkab255","journal-title":"Nucleic Acids Research"},{"key":"1311_CR37","unstructured":"Schr\u00f6dinger. (2022). Schr\u00f6dinger Release 2022-1: Desmond Molecular Dynamics System, D. E. Shaw Research, New York, NY, 2019. Maestro-Desmond Interoperability Tools. Schr\u00f6dinger."},{"key":"1311_CR38","doi-asserted-by":"publisher","unstructured":"Bowers, K. J., Sacerdoti, F. D., Salmon, J. K., Shan, Y., Shaw, D. E., Chow, E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., Klepeis, J. L., Kolossvary, I., & Moraes, M. A. (2006). Molecular dynamics\u2014Scalable algorithms for molecular dynamics simulations on commodity clusters. In Proceedings of the ACM\/IEEE SC2006 conference on high performance networking and computing, 2006. https:\/\/doi.org\/10.1145\/1188455.1188544","DOI":"10.1145\/1188455.1188544"},{"key":"1311_CR39","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1021\/ct100578z","volume":"7","author":"MHM Olsson","year":"2011","unstructured":"Olsson, M. H. M., S\u00f8ndergaard, C. R., Rostkowski, M., & Jensen, J. H. (2011). PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. Journal of Chemical Theory and Computation, 7, 525\u2013537.","journal-title":"Journal of Chemical Theory and Computation"},{"key":"1311_CR40","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark, P., & Nilsson, L. (2001). Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K. Journal of Physical Chemistry A, 105, 9954\u20139960.","journal-title":"Journal of Physical Chemistry A"},{"issue":"1","key":"1311_CR41","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1021\/acs.jctc.5b00864","volume":"12","author":"E Harder","year":"2015","unstructured":"Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2015). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281\u2013296. https:\/\/doi.org\/10.1021\/acs.jctc.5b00864","journal-title":"Journal of Chemical Theory and Computation"},{"key":"1311_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2020.104314","volume":"82","author":"S Skariyachan","year":"2020","unstructured":"Skariyachan, S., Muddebihalkar, A. G., Badrinath, V., Umashankar, B., Eram, D., Uttarkar, A., & Niranjan, V. (2020). Natural epiestriol-16 act as potential lead molecule against prospective molecular targets of multidrug resistant Acinetobacter baumannii\u2014Insight from in silico modelling and in vitro investigations. Infections Genetics and Evolution, 82, 104314.","journal-title":"Infections Genetics and Evolution"},{"issue":"19","key":"1311_CR43","doi-asserted-by":"publisher","first-page":"6150","DOI":"10.3390\/molecules27196150","volume":"27","author":"V Niranjan","year":"2022","unstructured":"Niranjan, V., Uttarkar, A., Murali, K., Niranjan, S., Gopal, J., & Kumar, J. (2022). Mycobacterium time-series genome analysis identifies AAC2\u2032 as a potential drug target with naloxone showing potential bait drug synergism. Molecules, 27(19), 6150. https:\/\/doi.org\/10.3390\/molecules27196150","journal-title":"Molecules"},{"key":"1311_CR44","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1002\/prot.23106","volume":"79","author":"J Li","year":"2011","unstructured":"Li, J., Abel, R., Zhu, K., Cao, Y., Zhao, S., & Friesner, R. A. (2011). The VSGB 2.0 model: A next generation energy model for high resolution protein structure modeling. Proteins: Structure, Function, and Bioinformatics, 79, 2794\u20132812.","journal-title":"Proteins: Structure, Function, and Bioinformatics"},{"key":"1311_CR45","doi-asserted-by":"publisher","first-page":"170","DOI":"10.6026\/97320630018170","volume":"18","author":"S Ahmad","year":"2022","unstructured":"Ahmad, S. (2022). Molecular dynamics simulation and docking analysis of NF-\u03baB protein binding with sulindac acid. Bioinformation, 18, 170\u2013179.","journal-title":"Bioinformation"},{"key":"1311_CR46","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/molecules28010089","volume":"28","author":"V Niranjan","year":"2023","unstructured":"Niranjan, V., Jayaprasad, S., Uttarkar, A., Kusanur, R., & Kumar, J. (2023). Design of novel coumarin derivatives as NUDT5 antagonists that act by restricting ATP synthesis in breast cancer cells. Molecules, 28, 89. https:\/\/doi.org\/10.3390\/molecules28010089","journal-title":"Molecules"},{"key":"1311_CR47","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1007\/s11033-023-08308-5","volume":"50","author":"SA Hussain","year":"2023","unstructured":"Hussain, S. A., & Venkatesh, T. (2023). YBX1\/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K\/AKT\/MTOR signaling in breast cancer cells. Molecular Biology Reports, 50, 3413\u20133428. https:\/\/doi.org\/10.1007\/s11033-023-08308-5","journal-title":"Molecular Biology Reports"},{"issue":"1","key":"1311_CR48","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1261\/rna.1175909","volume":"15","author":"D Weidensdorfer","year":"2008","unstructured":"Weidensdorfer, D., St\u00f6hr, N., Baude, A., Lederer, M., K\u00f6hn, M., Schierhorn, A., Buchmeier, S., Wahle, E., & H\u00fcttelmaier, S. (2008). Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs. RNA, 15(1), 104\u2013115. https:\/\/doi.org\/10.1261\/rna.1175909","journal-title":"RNA"},{"key":"1311_CR49","doi-asserted-by":"publisher","unstructured":"Feng, M., Xie, X., Han, G., Zhang, T., Li, Y., Li, Y., Yin, R., Wang, Q., Zhang, T., Wang, P., Hu, J., Cheng, Y., Gao, Z., Wang, J., Chang, J., Cui, M., Gao, K., Chai, J., Liu, W., . . . Zhang, H. (2021). YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner. Blood, 138(1), 71\u201385. https:\/\/doi.org\/10.1182\/blood.2020009676","DOI":"10.1182\/blood.2020009676"},{"issue":"6","key":"1311_CR50","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/1878-0261.12676","volume":"14","author":"Y Ban","year":"2020","unstructured":"Ban, Y., Tan, P., Cai, J., Li, J., Hu, M., Zhou, Y., Mei, Y., Tan, Y., Li, X., Zeng, Z., Xiong, W., Li, G., Li, X., Yi, M., & Xiang, B. (2020). LNCAROD is stabilized by m6A methylation and promotes cancer progression via forming a ternary complex with HSPA1A and YBX1 in head and neck squamous cell carcinoma. Molecular Oncology, 14(6), 1282\u20131296. https:\/\/doi.org\/10.1002\/1878-0261.12676","journal-title":"Molecular Oncology"},{"issue":"6","key":"1311_CR51","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1139\/bcb-2017-0147","volume":"95","author":"J Ausi\u00f3","year":"2017","unstructured":"Ausi\u00f3, J., & Georgel, P. (2017). MeCP2 and CTCF: Enhancing the cross-talk of silencers. Biochemistry and Cell Biology, 95(6), 593\u2013608. https:\/\/doi.org\/10.1139\/bcb-2017-0147","journal-title":"Biochemistry and Cell Biology"},{"key":"1311_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47360-9","author":"MK Gupta","year":"2019","unstructured":"Gupta, M. K., Polisetty, R. V., Sharma, R., Ganesh, R. A., Gowda, H., Purohit, A. K., Ankathi, P., Prasad, K., Mariswamappa, K., Lakshmikantha, A., Uppin, M. S., Sundaram, C., Gautam, P., & Sirdeshmukh, R. (2019). Altered transcriptional regulatory proteins in glioblastoma and YBX1 as a potential regulator of tumor invasion. Scientific Reports. https:\/\/doi.org\/10.1038\/s41598-019-47360-9","journal-title":"Scientific Reports"},{"key":"1311_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-019-1347-0","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Su, J., Wang, Y., Fu, D., Ideozu, J. E., Geng, H., Cui, Q., Wang, C., Chen, R., Yu, Y., Niu, Y., & Yue, D. (2019). The interaction of YBX1 with G3BP1 promotes renal cell carcinoma cell metastasis via YBX1\/G3BP1-SPP1- NF-\u03baB signaling axis. Journal of Experimental and Clinical Cancer Research. https:\/\/doi.org\/10.1186\/s13046-019-1347-0","journal-title":"Journal of Experimental and Clinical Cancer Research"},{"issue":"3","key":"1311_CR54","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12185-020-03027-0","volume":"113","author":"D Nishiyama","year":"2020","unstructured":"Nishiyama, D., Chinen, Y., Isa, R., Fujibayashi, Y., Kuwahara-Ota, S., Yamaguchi, J., Takimoto-Shimomura, T., Matsumura-Kimoto, Y., Tsukamoto, T., Shimura, Y., Kobayashi, T., Horiike, S., Taniwaki, M., Handa, H., & Kuroda, J. (2020). EWSR1 overexpression is a pro-oncogenic event in multiple myeloma. International Journal of Hematology, 113(3), 381\u2013394. https:\/\/doi.org\/10.1007\/s12185-020-03027-0","journal-title":"International Journal of Hematology"},{"issue":"12","key":"1311_CR55","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1016\/j.chembiol.2013.10.008","volume":"20","author":"A Rodina","year":"2013","unstructured":"Rodina, A., Patel, P. D., Kang, Y., Patel, Y., Baaklini, I., Wong, M. J., Taldone, T., Yan, P., Yang, C., Maharaj, R., Gozman, A., Patel, M. R., Patel, H. J., Chirico, W., Erdjument-Bromage, H., Talele, T. T., Young, J. C., & Chiosis, G. (2013). Identification of an allosteric pocket on human HSP70 reveals a mode of inhibition of this therapeutically important protein. Chemistry and Biology, 20(12), 1469\u20131480. https:\/\/doi.org\/10.1016\/j.chembiol.2013.10.008","journal-title":"Chemistry and Biology"},{"issue":"3","key":"1311_CR56","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/1541-7786.mcr-12-0547-t","volume":"11","author":"GM Balaburski","year":"2013","unstructured":"Balaburski, G. M., Leu, J. I., Beeharry, N., Hayik, S., Andrake, M. D., Zhang, G., Herlyn, M., Villanueva, J., Dunbrack, R. L., Yen, T., George, D. L., & Murphy, M. E. (2013). A modified HSP70 inhibitor shows broad activity as an anticancer agent. Molecular Cancer Research, 11(3), 219\u2013229. https:\/\/doi.org\/10.1158\/1541-7786.mcr-12-0547-t","journal-title":"Molecular Cancer Research"},{"issue":"7","key":"1311_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0103518","volume":"9","author":"P Zhang","year":"2014","unstructured":"Zhang, P., Leu, J. I., Murphy, M. E., George, D. L., & Marmorstein, R. (2014). Crystal structure of the stress-inducible human heat shock protein 70 substrate-binding domain in complex with peptide substrate. PLoS ONE, 9(7), e103518. https:\/\/doi.org\/10.1371\/journal.pone.0103518","journal-title":"PLoS ONE"},{"issue":"3","key":"1311_CR58","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/s0969-2126(97)00197-4","volume":"5","author":"MI Sriram","year":"1997","unstructured":"Sriram, M. I., Osipiuk, J., Freeman, B., Morimoto, R. I., & Joachimiak, A. (1997). Human Hsp70 molecular chaperone binds two calcium ions within the ATPase domain. Structure, 5(3), 403\u2013414. https:\/\/doi.org\/10.1016\/s0969-2126(97)00197-4","journal-title":"Structure"},{"issue":"21","key":"1311_CR59","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1073\/pnas.0903503106","volume":"106","author":"EB Bertelsen","year":"2009","unstructured":"Bertelsen, E. B., Chang, L., Gestwicki, J. E., & Zuiderweg, E. R. P. (2009). Solution conformation of wild-type E. coli Hsp70 (DnaK) chaperone complexed with ADP and substrate. Proceedings of the National Academy of Sciences of the United States of America, 106(21), 8471\u20138476. https:\/\/doi.org\/10.1073\/pnas.0903503106","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"2","key":"1311_CR60","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1006\/jmbi.2001.5334","volume":"316","author":"CPAM Kloks","year":"2002","unstructured":"Kloks, C. P. A. M., Spronk, C. A. E. M., Lasonder, E., Hoffmann, A., Vuister, G. W., Grzesiek, S., & Hilbers, C. W. (2002). The solution structure and DNA-binding properties of the cold-shock domain of the human Y-box protein YB-1. Journal of Molecular Biology, 316(2), 317\u2013326. https:\/\/doi.org\/10.1006\/jmbi.2001.5334","journal-title":"Journal of Molecular Biology"},{"issue":"16","key":"1311_CR61","doi-asserted-by":"publisher","first-page":"9361","DOI":"10.1093\/nar\/gkaa619","volume":"48","author":"J Zhang","year":"2020","unstructured":"Zhang, J., Fan, J., Li, S., Yang, Y., Sun, P., Zhu, Q., Wang, J., Jiang, B., Yang, D., & Liu, M. (2020). Structural basis of DNA binding to human YB-1 cold shock domain regulated by phosphorylation. Nucleic Acids Research, 48(16), 9361\u20139371. https:\/\/doi.org\/10.1093\/nar\/gkaa619","journal-title":"Nucleic Acids Research"},{"issue":"7","key":"1311_CR62","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1073\/pnas.1910862117","volume":"117","author":"F Zou","year":"2020","unstructured":"Zou, F., Tu, R., Duan, B., Yang, Z., Ping, Z., Song, X., Chen, S., Price, A., Li, H., Scott, A., Perera, A., Li, S., & Xie, T. (2020). Drosophila YBX1 homolog YPS promotes ovarian germ line stem cell development by preferentially recognizing 5-methylcytosine RNAs. Proceedings of the National Academy of Sciences of USA, 117(7), 3603\u20133609. https:\/\/doi.org\/10.1073\/pnas.1910862117","journal-title":"Proceedings of the National Academy of Sciences of USA"},{"issue":"1\u20132","key":"1311_CR63","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11010-017-3062-5","volume":"435","author":"R Jacob","year":"2017","unstructured":"Jacob, R., & Moorthy, A. (2017). IGF2BP1: A novel binding protein of p38 MAPK. Molecular and Cellular Biochemistry, 435(1\u20132), 133\u2013140. https:\/\/doi.org\/10.1007\/s11010-017-3062-5","journal-title":"Molecular and Cellular Biochemistry"},{"issue":"2","key":"1311_CR64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1101\/gad.1862910","volume":"24","author":"JA Chao","year":"2010","unstructured":"Chao, J. A., Patskovsky, Y., Patel, V., Levy, M., Almo, S. C., & Singer, R. H. (2010). ZBP1 recognition of \u03b2-actin zipcode induces RNA looping. Genes and Development, 24(2), 148\u2013158. https:\/\/doi.org\/10.1101\/gad.1862910","journal-title":"Genes and Development"},{"key":"1311_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/srep31210","author":"JY Chia","year":"2016","unstructured":"Chia, J. Y., Tan, W. S., Ng, C. L., Hu, N., Foo, H. L., & Ho, K. (2016). A\/T run geometry of B-form DNA is independent of bound Methyl-CPG binding domain, cytosine methylation and flanking sequence. Scientific Reports. https:\/\/doi.org\/10.1038\/srep31210","journal-title":"Scientific Reports"},{"issue":"12","key":"1311_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080947","volume":"8","author":"T Vognsen","year":"2013","unstructured":"Vognsen, T., M\u00f6ller, I. R., & Kristensen, O. (2013). Crystal structures of the human G3BP1 NTF2-like domain visualize FxFG Nup repeat specificity. PLoS ONE, 8(12), e80947. https:\/\/doi.org\/10.1371\/journal.pone.0080947","journal-title":"PLoS ONE"},{"key":"1311_CR67","doi-asserted-by":"publisher","unstructured":"Nagata, T., Muto, Y., Inoue, M., Kigawa, T., Terada, T., Shirouzu, M., Yokoyama, S., & RIKEN Structural Genomics\/Proteomics Initiative (RSGI). (2005). Solution structure of the RNA recognition motif of Ewing Sarcoma (EWS) protein. https:\/\/doi.org\/10.2210\/pdb2CPE\/pdb","DOI":"10.2210\/pdb2CPE\/pdb"},{"issue":"1","key":"1311_CR68","doi-asserted-by":"publisher","first-page":"46277","DOI":"10.1038\/srep46277","volume":"7","author":"D Lagorce","year":"2017","unstructured":"Lagorce, D., Douguet, D., Miteva, M. A., & Villoutreix, B. O. (2017). Computational analysis of calculated physicochemical and ADMET properties of protein\u2013protein interaction inhibitors. Scientific Reports, 7(1), 46277. https:\/\/doi.org\/10.1038\/srep46277","journal-title":"Scientific Reports"},{"key":"1311_CR69","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.addr.2016.04.029","volume":"101","author":"CA Lipinski","year":"2016","unstructured":"Lipinski, C. A. (2016). Rule of Five in 2015 and beyond: Target and ligand structural limitations, ligand chemistry structure and drug discovery project decisions. Advanced Drug Delivery Reviews, 101, 34\u201341. https:\/\/doi.org\/10.1016\/j.addr.2016.04.029","journal-title":"Advanced Drug Delivery Reviews"},{"key":"1311_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-00315-3","author":"H Lu","year":"2020","unstructured":"Lu, H., Zhou, Q., He, J., Jiang, Z., Peng, C., Tong, R., & Shi, J. (2020). Recent advances in the development of protein\u2013protein interactions modulators: Mechanisms and clinical trials. Signal Transduction and Targeted Therapy. https:\/\/doi.org\/10.1038\/s41392-020-00315-3","journal-title":"Signal Transduction and Targeted Therapy"},{"issue":"12","key":"1311_CR71","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1038\/nrd1902","volume":"4","author":"BT Hennessy","year":"2005","unstructured":"Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005). Exploiting the PI3K\/AKT pathway for cancer drug discovery. Nature Reviews Drug Discovery, 4(12), 988\u20131004. https:\/\/doi.org\/10.1038\/nrd1902","journal-title":"Nature Reviews Drug Discovery"},{"issue":"2","key":"1311_CR72","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1615\/critrevoncog.v17.i2.70","volume":"17","author":"L Zhang","year":"2012","unstructured":"Zhang, L., & Daly, R. J. (2012). Targeting the human kinome for cancer therapy: Current perspectives. Critical Reviews in Oncogenesis, 17(2), 233\u2013246. https:\/\/doi.org\/10.1615\/critrevoncog.v17.i2.70","journal-title":"Critical Reviews in Oncogenesis"},{"issue":"1","key":"1311_CR73","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/imr.12244","volume":"263","author":"T Cierpicki","year":"2014","unstructured":"Cierpicki, T., & Grembecka, J. (2014). Targeting protein\u2013protein interactions in hematologic malignancies: Still a challenge or a great opportunity for future therapies? Immunological Reviews, 263(1), 279\u2013301. https:\/\/doi.org\/10.1111\/imr.12244","journal-title":"Immunological Reviews"},{"issue":"8","key":"1311_CR74","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nrc864","volume":"2","author":"KH Vousden","year":"2002","unstructured":"Vousden, K. H., & L\u00fc, X. (2002). Live or let die: The cell\u2019s response to p53. Nature Reviews Cancer, 2(8), 594\u2013604. https:\/\/doi.org\/10.1038\/nrc864","journal-title":"Nature Reviews Cancer"},{"key":"1311_CR75","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2016.00007","author":"A Burgess","year":"2016","unstructured":"Burgess, A., Chia, K. K., Haupt, S., Thomas, D. M., Haupt, Y., & Lim, E. (2016). Clinical overview of MDM2\/X-targeted therapies. Frontiers in Oncology. https:\/\/doi.org\/10.3389\/fonc.2016.00007","journal-title":"Frontiers in Oncology"},{"issue":"8","key":"1311_CR76","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1002\/cmdc.201500487","volume":"11","author":"N Estrada-Ortiz","year":"2015","unstructured":"Estrada-Ortiz, N., Neochoritis, C. G., & D\u00f6mling, A. (2015). How to design a successful P53-MDM2\/X interaction inhibitor: A thorough overview based on crystal structures. ChemMedChem, 11(8), 757\u2013772. https:\/\/doi.org\/10.1002\/cmdc.201500487","journal-title":"ChemMedChem"},{"key":"1311_CR77","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-022-00412-8","author":"J Shi","year":"2022","unstructured":"Shi, J., Jin, X., Wang, Y., Zhu, T., Zhang, D., Li, Q., Zhong, X., Deng, Y., Shen, J., & Fan, X. (2022). LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression. Oncogenesis. https:\/\/doi.org\/10.1038\/s41389-022-00412-8","journal-title":"Oncogenesis"},{"issue":"5659","key":"1311_CR78","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1126\/science.1092472","volume":"303","author":"LT Vassilev","year":"2004","unstructured":"Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhi, N., & Liu, E. A. (2004). In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science, 303(5659), 844\u2013848. https:\/\/doi.org\/10.1126\/science.1092472","journal-title":"Science"},{"issue":"3","key":"1311_CR79","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrd.2017.227","volume":"17","author":"PJ Carter","year":"2017","unstructured":"Carter, P. J., & Lazar, G. A. (2017). Next generation antibody drugs: Pursuit of the \u201chigh-hanging fruit.\u201d Nature Reviews Drug Discovery, 17(3), 197\u2013223. https:\/\/doi.org\/10.1038\/nrd.2017.227","journal-title":"Nature Reviews Drug Discovery"},{"key":"1311_CR80","doi-asserted-by":"publisher","unstructured":"Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., Huang, D. C. S., Hymowitz, S. G., Jin, S., Khaw, S. L., Kovar, P. J., Lam, L. T., Lee, J., Maecker, H. L., Marsh, K. C., . . . Elmore, S. W. (2013). ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nature Medicine, 19(2), 202\u2013208. https:\/\/doi.org\/10.1038\/nm.3048","DOI":"10.1038\/nm.3048"},{"issue":"5","key":"1311_CR81","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1042\/bst20210749","volume":"49","author":"EF Lee","year":"2021","unstructured":"Lee, E. F., & Fairlie, W. D. (2021). Discovery, development and application of drugs targeting BCL-2 pro-survival proteins in cancer. Biochemical Society Transactions, 49(5), 2381\u20132395. https:\/\/doi.org\/10.1042\/bst20210749","journal-title":"Biochemical Society Transactions"},{"issue":"17","key":"1311_CR82","doi-asserted-by":"publisher","first-page":"4874","DOI":"10.1182\/bloodadvances.2022009648","volume":"7","author":"H Li","year":"2023","unstructured":"Li, H., Zhang, D., Fu, Q., Wang, S., Wang, Z., Zhang, X., Chen, X., Zhu, X., An, N., Chen, Y., Zhou, L., Lu, D., & Zhao, N. (2023). YBX1 as an oncogenic factor in T-cell acute lymphoblastic leukemia. Blood Advances, 7(17), 4874\u20134885. https:\/\/doi.org\/10.1182\/bloodadvances.2022009648","journal-title":"Blood Advances"},{"issue":"8","key":"1311_CR83","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1016\/j.chembiol.2021.02.014","volume":"28","author":"D Tailor","year":"2021","unstructured":"Tailor, D., Resendez, A., Garcia-Marques, F. J., Pandrala, M., Going, C. C., Bermudez, A., Kumar, V., Rafat, M., Nambiar, D. K., Honkala, A., Le, Q., Sledge, G. W., Graves, E., Pitteri, S. J., & Malhotra, S. V. (2021). Y box binding protein 1 inhibition as a targeted therapy for ovarian cancer. Cell Chemical Biology, 28(8), 1206-1220.e6. https:\/\/doi.org\/10.1016\/j.chembiol.2021.02.014","journal-title":"Cell Chemical Biology"},{"issue":"7","key":"1311_CR84","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.3390\/cells11071217","volume":"11","author":"Q Yin","year":"2022","unstructured":"Yin, Q., Zheng, M., Luo, Q., Jiang, D., Zhang, H., & Chen, C. (2022). YB-1 as an oncoprotein: Functions, regulation, post-translational modifications, and targeted therapy. Cells, 11(7), 1217. https:\/\/doi.org\/10.3390\/cells11071217","journal-title":"Cells"},{"key":"1311_CR85","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2022.5110","author":"S Han","year":"2022","unstructured":"Han, S., Lee, J., Woo, J., Jung, G., Jung, S., Han, E., Park, Y., Kim, B., Kim, S., Park, B., Choi, C., & Jung, J. (2022). Myricetin induces apoptosis through the MAPK pathway and regulates JNK mediated autophagy in SK BR 3 cells. International Journal of Molecular Medicine. https:\/\/doi.org\/10.3892\/ijmm.2022.5110","journal-title":"International Journal of Molecular Medicine"},{"issue":"11","key":"1311_CR86","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/ph14111069","volume":"14","author":"P Pandey","year":"2021","unstructured":"Pandey, P., Khan, F., Qari, H. A., & Oves, M. (2021). Rutin (bioflavonoid) as cell signaling pathway modulator: Prospects in treatment and chemoprevention. Pharmaceuticals (Basel, Switzerland), 14(11), 1069. https:\/\/doi.org\/10.3390\/ph14111069","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"11","key":"1311_CR87","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1681\/asn.2014080846","volume":"26","author":"W Dong","year":"2015","unstructured":"Dong, W., Wang, H., Shahzad, K., Bock, F., Al-Dabet, M. M., Ranjan, S., Wolter, J., Kohli, S., Hoffmann, J., Dhople, V. M., Zhu, C., Lindquist, J. A., Esmon, C. T., Gr\u00f6ne, E., Gr\u00f6ne, H., Madhusudhan, T., Mertens, P. R., Schl\u00fcter, D., & Isermann, B. (2015). Activated protein C ameliorates renal Ischemia-Reperfusion injury by restricting Y-Box binding protein-1 ubiquitination. Journal of the American Society of Nephrology, 26(11), 2789\u20132799. https:\/\/doi.org\/10.1681\/asn.2014080846","journal-title":"Journal of the American Society of Nephrology"},{"issue":"8","key":"1311_CR88","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/ptr.6081","volume":"32","author":"S Li","year":"2018","unstructured":"Li, S., Zhao, Q., Wang, B., Yuan, S., Wang, X., & Li, K. (2018). Quercetin reversed MDR in breast cancer cells through down-regulating P-GP expression and eliminating cancer stem cells mediated by YB-1 nuclear translocation. Phytotherapy Research, 32(8), 1530\u20131536. https:\/\/doi.org\/10.1002\/ptr.6081","journal-title":"Phytotherapy Research"},{"key":"1311_CR89","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10745","volume":"9","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q., Feng, Z., Gao, M., & Guo, L. (2021). Determining novel candidate anti-hepatocellular carcinoma drugs using interaction networks and molecular docking between drug targets and natural compounds of SiNiSan. PeerJ, 9, e10745. https:\/\/doi.org\/10.7717\/peerj.10745","journal-title":"PeerJ"},{"key":"1311_CR90","doi-asserted-by":"publisher","first-page":"3255","DOI":"10.2147\/dddt.s319786","volume":"15","author":"J Liu","year":"2021","unstructured":"Liu, J., Liu, J., Tong, X., Peng, W., Wei, S., Sun, T., Wang, Y., Zhang, B., & Li, W. (2021). Network Pharmacology prediction and molecular docking-based strategy to discover the potential pharmacological mechanism of Huai Hua San against ulcerative colitis. Drug Design Development and Therapy, 15, 3255\u20133276. https:\/\/doi.org\/10.2147\/dddt.s319786","journal-title":"Drug Design Development and Therapy"},{"key":"1311_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2023.109867","volume":"188","author":"S Khozooei","year":"2023","unstructured":"Khozooei, S., Veerappan, S., Bonzheim, I., Singer, S., Gani, C., & Toulany, M. (2023). Fisetin overcomes non-targetability of mutated KRAS induced YB-1 signaling in colorectal cancer cells and improves radiosensitivity by blocking repair of radiation-induced DNA double-strand breaks. Radiotherapy and Oncology, 188, 109867. https:\/\/doi.org\/10.1016\/j.radonc.2023.109867","journal-title":"Radiotherapy and Oncology"},{"issue":"3","key":"1311_CR92","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1021\/mp100305h","volume":"8","author":"AA Date","year":"2011","unstructured":"Date, A. A., Nagarsenker, M. S., Patere, S., Dhawan, V., Gude, R. P., Hassan, P. A., Aswal, V., Steiniger, F., Thamm, J., & Fahr, A. (2011). Lecithin-based novel cationic nanocarriers (Leciplex) II: Improving therapeutic efficacy of quercetin on oral administration. Molecular Pharmaceutics, 8(3), 716\u2013726. https:\/\/doi.org\/10.1021\/mp100305h","journal-title":"Molecular Pharmaceutics"},{"issue":"18","key":"1311_CR93","doi-asserted-by":"publisher","first-page":"14158","DOI":"10.3390\/ijms241814158","volume":"24","author":"J Szymczak","year":"2023","unstructured":"Szymczak, J., & Cielecka-Piontek, J. (2023). Fisetin\u2014In search of better bioavailability\u2014From macro to nano modifications: A review. International Journal of Molecular Sciences, 24(18), 14158. https:\/\/doi.org\/10.3390\/ijms241814158","journal-title":"International Journal of Molecular Sciences"},{"issue":"7","key":"1311_CR94","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","volume":"21","author":"CF Thorn","year":"2011","unstructured":"Thorn, C. F., Oshiro, C., Marsh, S., Hernandez-Boussard, T., McLeod, H., Klein, T. E., & Altman, R. B. (2011). Doxorubicin pathways: Pharmacodynamics and adverse effects. Pharmacogenetics and Genomics, 21(7), 440\u2013446. https:\/\/doi.org\/10.1097\/FPC.0b013e32833ffb56","journal-title":"Pharmacogenetics and Genomics"},{"issue":"2","key":"1311_CR95","doi-asserted-by":"publisher","first-page":"1000164","DOI":"10.4172\/2157-7439.1000164","volume":"4","author":"P Ma","year":"2013","unstructured":"Ma, P., & Mumper, R. J. (2013). Paclitaxel nano-delivery systems: A comprehensive review. Journal of Nanomedicine and Nanotechnology, 4(2), 1000164. https:\/\/doi.org\/10.4172\/2157-7439.1000164","journal-title":"Journal of Nanomedicine and Nanotechnology"},{"key":"1311_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.532285","volume":"10","author":"ACL Mortensen","year":"2020","unstructured":"Mortensen, A. C. L., Mohajershojai, T., Hariri, M., Pettersson, M., & Spiegelberg, D. (2020). Overcoming limitations of cisplatin therapy by additional treatment with the HSP90 inhibitor onalespib. Frontiers in Oncology, 10, 532285. https:\/\/doi.org\/10.3389\/fonc.2020.532285","journal-title":"Frontiers in Oncology"},{"issue":"8","key":"1311_CR97","doi-asserted-by":"publisher","first-page":"110434","DOI":"10.1016\/j.isci.2024.110434","volume":"27","author":"H Ji","year":"2024","unstructured":"Ji, H., Zhang, Z., Chen, C., Xu, W., Liu, T., Dong, Y., Wang, J., Wang, H., & Zhu, X. (2024). The impact of quercetin and paclitaxel combination on ovarian cancer cells. iScience, 27(8), 110434. https:\/\/doi.org\/10.1016\/j.isci.2024.110434","journal-title":"iScience"},{"issue":"3","key":"1311_CR98","doi-asserted-by":"publisher","first-page":"902","DOI":"10.3390\/cancers15030902","volume":"15","author":"S Sharma","year":"2023","unstructured":"Sharma, S., Cwiklinski, K., Mahajan, S. D., Schwartz, S. A., & Aalinkeel, R. (2023). Combination modality using quercetin to enhance the efficacy of docetaxel in prostate cancer cells. Cancers, 15(3), 902. https:\/\/doi.org\/10.3390\/cancers15030902","journal-title":"Cancers"},{"issue":"2","key":"1311_CR99","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1158\/1535-7163.MCT-10-0606","volume":"10","author":"R Tripathi","year":"2011","unstructured":"Tripathi, R., Samadder, T., Gupta, S., Surolia, A., & Shaha, C. (2011). Anticancer activity of a combination of cisplatin and fisetin in embryonal carcinoma cells and xenograft tumors. Molecular Cancer Therapeutics, 10(2), 255\u2013268. https:\/\/doi.org\/10.1158\/1535-7163.MCT-10-0606","journal-title":"Molecular Cancer Therapeutics"},{"issue":"3","key":"1311_CR100","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/ijms19030661","volume":"19","author":"A Klimaszewska-Wi\u015bniewska","year":"2018","unstructured":"Klimaszewska-Wi\u015bniewska, A., Ha\u0142as-Wi\u015bniewska, M., Grzanka, A., & Grzanka, D. (2018). Evaluation of anti-metastatic potential of the combination of fisetin with paclitaxel on A549 non-small cell lung cancer cells. International Journal of Molecular Sciences, 19(3), 661. https:\/\/doi.org\/10.3390\/ijms19030661","journal-title":"International Journal of Molecular Sciences"},{"key":"1311_CR101","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tifs.2021.11.032","volume":"119","author":"K Kandemir","year":"2022","unstructured":"Kandemir, K., Tomas, M., McClements, D. J., & Capanoglu, E. (2022). Recent advances on the improvement of quercetin bioavailability. Trends in Food Science and Technology, 119, 192\u2013200. https:\/\/doi.org\/10.1016\/j.tifs.2021.11.032","journal-title":"Trends in Food Science and Technology"},{"key":"1311_CR102","doi-asserted-by":"publisher","first-page":"196","DOI":"10.3390\/ph16020196","volume":"16","author":"RM Kumar","year":"2023","unstructured":"Kumar, R. M., Kumar, H., Bhatt, T., Jain, R., Panchal, K., Chaurasiya, A., & Jain, V. (2023). Fisetin in cancer: Attributes, developmental aspects, and nanotherapeutics. Pharmaceuticals, 16, 196. https:\/\/doi.org\/10.3390\/ph16020196","journal-title":"Pharmaceuticals"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-024-01311-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-024-01311-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T04:18:28Z","timestamp":1761711508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-024-01311-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,20]]},"references-count":102,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1007\/s12033-024-01311-6","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,20]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}